FDA Inspection
Bruce G. Redman, D.O.Bruce G. Redman, D.O. – FDA Inspection, Jan 9, 2009
Record Details
This FDA Inspection record concerns Bruce G. Redman, D.O., with an inspection on January 9, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Bruce G. Redman, D.O.
- Inspection Date
- January 9, 2009
- Product Type
- Biologics
View Company Profile
ID · 8d0ad341-f1e6-4c32-9481-5ccfcbb5c160
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 555423
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
7- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.53(c)(1)Investigator statement (FDA 1572)
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
- 21 CFR 50.20Consent not obtained, exceptions do not apply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bruce G. Redman, D.O.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 11, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bruce G. Redman, D.O.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.